• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Jaguar Health, Inc. - Common Stock (NQ:JAGX)

    0.6770 -0.0330 (-4.65%)
    Streaming Delayed Price Updated: 2:11 PM EST, Jan 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 605,992
    Open 0.7100
    Bid (Size) 0.6761 (400)
    Ask (Size) 0.6864 (100)
    Prev. Close 0.7100
    Today's Range 0.6634 - 0.7100
    52wk Range 0.6401 - 25.75
    Shares Outstanding 171,350,166
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi
    Via ACCESS Newswire
    Here are the top movers in Tuesday's session. ↗
    Via Chartmill

    Performance

    YTD
    -32.1%
    -32.1%
    1 Month
    -34.3%
    -34.3%
    3 Month
    -67.1%
    -67.1%
    6 Month
    -69.1%
    -69.1%
    1 Year
    -97.0%
    -97.0%

    More News

    Read More
    Unusual volume stocks are being observed in Tuesday's session. ↗
    Via Chartmill
    Tuesday's session: top gainers and losers ↗
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    Which stocks are moving after the closing bell on Monday? ↗
    Via Chartmill
    Get insights into the top gainers and losers of Friday's after-hours session. ↗
    Via Chartmill
    Which stocks are experiencing notable movement on Friday? ↗
    Via Chartmill
    Curious about the most active stocks on Friday? ↗
    Via Chartmill
    News headline image
    The Surge In Jaguar Health Stock: What's Happening Now? ↗
    Via Benzinga
    Keep an eye on the top gainers and losers in Friday's session. ↗
    Via Chartmill
    Friday's session: gap up and gap down stocks ↗
    Via Chartmill
    Get insights into the top gainers and losers of Friday's pre-market session. ↗
    Via Chartmill
    News headline image
    Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts
    Via ACCESS Newswire
    Unusual volume stocks are being observed in Tuesday's session. ↗
    Via Chartmill
    News headline image
    Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million
    Via ACCESS Newswire
    News headline image
    Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication
    Via ACCESS Newswire
    News headline image
    Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
    Via ACCESS Newswire
    News headline image
    Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
    Via ACCESS Newswire
    News headline image
    FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
    Via ACCESS Newswire
    News headline image
    Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders
    Via ACCESS Newswire
    News headline image
    Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study
    Via ACCESS Newswire
    News headline image
    Get insights into the top gainers and losers of Monday's after-hours session. ↗
    Via Chartmill
    News headline image
    Jaguar Health Secures New Patent for Crofelemer in Short Bowel Syndrome, Strengthening Global IP Position Ahead of Additional Clinical Milestones
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Jaguar Health, Inc. - Common Stock publicly traded?
    Yes, Jaguar Health, Inc. - Common Stock is publicly traded.
    What exchange does Jaguar Health, Inc. - Common Stock trade on?
    Jaguar Health, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Jaguar Health, Inc. - Common Stock?
    The ticker symbol for Jaguar Health, Inc. - Common Stock is JAGX on the Nasdaq Stock Market
    What is the current price of Jaguar Health, Inc. - Common Stock?
    The current price of Jaguar Health, Inc. - Common Stock is 0.6770
    When was Jaguar Health, Inc. - Common Stock last traded?
    The last trade of Jaguar Health, Inc. - Common Stock was at 01/28/26 02:11 PM ET
    What is the market capitalization of Jaguar Health, Inc. - Common Stock?
    The market capitalization of Jaguar Health, Inc. - Common Stock is 116.00M
    How many shares of Jaguar Health, Inc. - Common Stock are outstanding?
    Jaguar Health, Inc. - Common Stock has 116M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.